Johnson & J 's ( 2012 ) strategy to fight the more than 100,000 lawsuits against it in bankruptcy is a strategy to deter future claims it thinks are " without merit " , according to lawyers representing the pharma giant . J&J faces paying billions in compensation , but legal experts said the company has won its fair share of cases too and could emulate Merck by eventually committing to less costly litigation .
Johnson & Johnson's (J&J) decision to fight the more than 100,000 lawsuits against it in court is a strategy to deter future claims it thinks are "without merit", according to lawyers battling the pharma giant. J&J faces paying billions in compensation, but legal experts said the company has won its fair share of cases too and could emulate Merck by eventually moving to less costly settlements.